Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Myocarditis IV: Nursing Management

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pioneers in Dermatology and Venereology: an Interview with Professor Beatrix Volc-Platzer.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022

Same author

Fumaric acid esters for paediatric psoriasis.

The British journal of dermatology·2021

Same author

Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl.

The British journal of dermatology·2020

Same author

Paraneoplastic Dermatomyositis: relevance of myositis-specific autoantibodies in a small cohort.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Same author

Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.

The British journal of dermatology·2019

Same author

Patch granuloma annulare: clinicopathological characteristics and response to phototherapy.

The British journal of dermatology·2019

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

[Update: dermatomyositis].

B Volc-Platzer¹

¹Fachärztin für Haut- und Geschlechtskrankheiten, Wien, Osterreich, beatrix.volc-platzer@wienkav.at.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete

|January 22, 2010

Summary

This summary is machine-generated.

Dermatomyositis, an idiopathic inflammatory myopathy, presents with characteristic skin and muscle symptoms. Early corticosteroid treatment significantly improves outcomes for most patients.

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

Area of Science:

Rheumatology
Immunology
Neurology

Context:

Dermatomyositis is a rare idiopathic inflammatory myopathy, classified as an orphan disease with an incidence of 1:100,000.
It presents a heterogeneous clinical spectrum, including periorbital heliotrope erythema, Gottron papules, and proximal muscle weakness.
The condition can overlap with other connective tissue diseases, and approximately one-third of patients have an underlying malignancy (paraneoplastic dermatomyositis).

Purpose:

To outline the clinical presentation, diagnostic considerations, and management strategies for dermatomyositis.
To highlight the correlation between muscle-specific antibody profiles and clinical variants.
To emphasize the importance of malignancy screening in patients with dermatomyositis.

Summary:

The mainstay of treatment involves high-dose oral corticosteroids until clinical improvement or normalization of muscle enzymes.
Alternative or adjunctive therapies include steroid-sparing immunosuppressants and high-dose intravenous immunoglobulins.
Prognosis has significantly improved with corticosteroid therapy, with approximately 90% of patients showing a positive response.

Impact:

Improved understanding of dermatomyositis clinical heterogeneity and diagnostic markers.
Established treatment guidelines emphasizing corticosteroids and supportive immunosuppressive therapies.
Enhanced patient outcomes and prognosis due to effective treatment strategies and vigilant malignancy surveillance.